It is therefore tempting to speculate that the nuclear presence of Bcl-3 as after IL-6 stimulation activates a different set of genes than activation of the classical and/or alternative NFκB pathway in myeloma cells. The gene discussed is IL6; the disease is plasma cell myeloma.